Drug intelligence / Profile preview

dengue vaccine (Indian Immunologicals)

Development stage
Unknown
Lead developer
Indian Immunologicals
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

The dengue vaccine developed by Indian Immunologicals Limited (IIL) is a recombinant vector vaccine currently in Phase I clinical development for the prevention of dengue fever. Developed in collaboration with the U.S. National Institutes of Health (NIH), which provided the necessary virus strains, the vaccine is designed to elicit a protective immune response against the dengue virus. It is administered via the subcutaneous route. Early clinical data from approximately 90 participants aged 18-50 showed no adverse effects. IIL, a subsidiary of the National Dairy Development Board, anticipates a commercial launch by 2026-2027, following the completion of Phase II trials and regulatory approvals.

Other names
IIL dengue vaccineIndian Immunologicals dengue vaccine

Beyond the preview

Go deeper on dengue vaccine (Indian Immunologicals).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dengue vaccine (Indian Immunologicals).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call